Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells.
about
Methotrexate Is a JAK/STAT Pathway InhibitorPhase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies.Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial.Metabolism pathways in chronic lymphocytic leukemia.Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristicsAt High Levels, Constitutively Activated STAT3 Induces Apoptosis of Chronic Lymphocytic Leukemia Cells.MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis.Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein-Barr virus-positive patients with chronic lymphocytic leukemiaSTAT3 as a possible therapeutic target in human malignancies: lessons from acute myeloid leukemia.Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) - gene transcription, cell cycle regulation, metabolism and intercellular communication.Pro-survival signal inhibition by CDK inhibitor dinaciclib in Chronic Lymphocytic Leukaemia.Activating STAT6 mutations in follicular lymphoma.Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199).Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia.Tris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cells.Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia.Proteomics profiling identifies induction of caveolin-1 in chronic lymphocytic leukemia cells by bone marrow stromal cells.NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib.Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway.Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cells.B-cell targeting in chronic Graft-versus-Host disease.PPAR-delta modulates membrane cholesterol and cytokine signaling in malignant B cells.Microenvironment-induced PIM kinases promote CXCR4-triggered mTOR pathway required for chronic lymphocytic leukaemia cell migration.miR-337-3p suppresses the proliferation and invasion of hepatocellular carcinoma cells through targeting JAK2.Crizotinib induces apoptosis of lung cancer cells through JAK-STAT pathwaySTAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cells
P2860
Q28546079-8CF3DADA-D35C-458D-BC2F-80CAED3587FEQ33422320-DDD3C849-669E-4EFA-9441-2EBE454C1807Q33438420-CEFB971C-AEFA-4521-AA63-DB661ADC0D4CQ36693111-BB9C2C72-F751-4F5A-8F55-8AF17196F76DQ36814056-E64B7BEC-EC8A-4C2E-8F4E-0220B1C32622Q36906043-D37BA7EA-ABD3-4FF3-9477-2B047B3CBD1FQ37315021-0D2DC0F4-903F-46EB-9F70-73BFE12E21B7Q37321119-A91F5610-57B7-4543-96EA-F6F1E5E8D1C6Q38265472-32B504D4-B487-4FA2-8A2A-706B2BCEE9D5Q38401664-C6E2054E-3EF0-4C03-929D-A49073BF16FAQ38755091-31107395-4AA8-45A3-AF91-1ABDA26A6EB8Q38937478-7C6D72A0-6D12-4CC0-B7C7-62DC800C184DQ39065374-8A50C060-3AC8-488B-9B9F-6A41F3893986Q39414732-4F30AFED-881E-428A-AB34-5FD5CF1D5552Q41652556-A48EF04E-6EF4-4971-B4AC-D8B1EFB2E37CQ42037602-1B88B233-4069-407C-B030-1D09503F7270Q46325508-374FB423-2025-4E73-8D08-0EB2E813F395Q47710385-DDEBF412-5384-41CE-8803-9441D468B34FQ47786604-05A550A8-125F-4A4B-B18F-47DAC54D8045Q47875518-6E996C69-928B-4F15-B07C-B0368C5CECA0Q48103978-9B05E330-2BAE-4ACC-94AA-76847D5D5A9FQ50044417-36B3FD29-EF35-4333-9331-06044CA87E55Q50972583-36B82E33-0FCD-46D6-A202-7602A727E3E8Q52582842-111AB3A5-3213-4867-855F-B5A91F1E9A70Q55090509-43F5EA05-4123-4899-B337-73FBA0C49160Q58573381-9CB914BB-3F56-465E-8894-4EF26DD0B943Q58739880-2F1D95F1-F07F-4A46-9A4F-65F831734500
P2860
Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Stimulation of the B-cell rece ...... ic lymphocytic leukemia cells.
@ast
Stimulation of the B-cell rece ...... ic lymphocytic leukemia cells.
@en
type
label
Stimulation of the B-cell rece ...... ic lymphocytic leukemia cells.
@ast
Stimulation of the B-cell rece ...... ic lymphocytic leukemia cells.
@en
prefLabel
Stimulation of the B-cell rece ...... ic lymphocytic leukemia cells.
@ast
Stimulation of the B-cell rece ...... ic lymphocytic leukemia cells.
@en
P2093
P2860
P50
P1433
P1476
Stimulation of the B-cell rece ...... ic lymphocytic leukemia cells.
@en
P2093
David M Harris
Inbal Hazan-Halevy
Jan A Burger
Ji Yuan Wu
Nitin Jain
Uri Rozovski
Zhiming Liu
P2860
P304
P356
10.1182/BLOOD-2013-10-534073
P407
P577
2014-04-28T00:00:00Z